Menu

Anti-Vax Flick Pulled from Film Festival

Tribeca Film Festival organizers reverse their decision to screen a documentary by discredited researcher Andrew Wakefield.

Mar 28, 2016
Tracy Vence

FLICKR, TROY TOLLEYDays after it was announced as part of this year’s Tribeca Film Festival lineup, the event’s organizers have canceled the screening of an anti-vaccination documentary directed and cowritten by Andrew Wakefield, the discredited researcher who published fraudulent data suggesting a link between measles, mumps, and rubella vaccination and autism. According to the Associated Press (AP), festival cofounder Robert DeNiro at first defended the film’s inclusion in in the event lineup, but changed his mind after consulting scientists.

“We do not believe it contributes to or furthers the discussion I had hoped for,” DeNiro said in a statement (via the AP). As STAT News reported, promotional materials for the film have been removed from the event’s website.

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.